Bayesian Experimental Design: An Alternative to Frequentist Methods

Bayesian vs. Frequentist Thinking

The fundamental difference lies in what probability means. In frequentist statistics, probability refers to the long-run frequency of events. A 95% confidence interval does not mean there is a 95% probability that the true parameter lies within the interval. It means that if you repeated the experiment infinitely many times, 95% of the computed intervals would contain the true parameter. The particular interval you calculated either contains the truth or it does not, and frequentist probability cannot assign a number to that specific case.

In Bayesian statistics, probability represents a degree of belief. A 95% credible interval means there is, given the data and the prior, a 95% probability that the true parameter lies within the interval. This is the interpretation that most non-statisticians intuitively want when they see a confidence interval, and it is the interpretation that only Bayesian methods actually support.

Bayesian analysis combines prior information (what was known before the experiment) with the likelihood (what the data say) to produce a posterior distribution (updated beliefs after seeing the data). The mathematical engine is Bayes theorem: the posterior is proportional to the prior times the likelihood. When data are abundant, the prior has little influence and Bayesian and frequentist conclusions converge. When data are sparse, the prior has more influence, which can be either an advantage (incorporating legitimate prior knowledge) or a concern (if the prior is poorly chosen).

Bayesian Hypothesis Testing

Instead of p-values, Bayesian hypothesis testing uses Bayes factors, which quantify the relative evidence for one hypothesis over another. A Bayes factor of 10 means the data are 10 times more likely under the alternative hypothesis than under the null. A Bayes factor of 0.1 means the data are 10 times more likely under the null than under the alternative. Unlike p-values, Bayes factors can provide evidence in favor of the null hypothesis, not just against it.

This ability to quantify evidence for null effects is practically important. In frequentist statistics, a non-significant p-value could mean the effect does not exist or that the study was too small to detect it. There is no way to distinguish these interpretations. A Bayes factor can clearly indicate that the data support the null hypothesis, helping researchers make informed decisions about whether to pursue a line of inquiry further or conclude that the effect is likely absent.

Bayes factors also do not suffer from the multiple comparisons problem in the same way that p-values do. Because Bayes factors quantify the relative evidence from the data rather than the probability of observing the data under a null hypothesis, they are inherently less sensitive to the number of tests conducted. This does not mean Bayesian analyses are immune to multiple testing concerns, but the framework handles them more naturally through the specification of prior probabilities.

Specifying Priors

The prior distribution encodes what is known about the parameter before collecting data. Informative priors incorporate specific prior knowledge, such as effect sizes from previous meta-analyses or physiological constraints on possible parameter values. For example, if a meta-analysis of similar interventions found effects centered around d = 0.3 with a standard deviation of 0.15, a normal prior with mean 0.3 and standard deviation 0.15 captures this knowledge.

Weakly informative priors express general knowledge without being strongly committed to specific values. They rule out implausible parameter values (e.g., a drug cannot reduce blood pressure by 200 mmHg) while remaining agnostic about plausible values. These priors are useful when prior knowledge is limited and the researcher wants the data to dominate the posterior.

Non-informative or objective priors attempt to let the data speak for themselves by assigning equal probability to all possible parameter values. Flat priors over an infinite range are technically improper (they do not integrate to 1), but they often produce valid posteriors. Jeffreys priors and reference priors are mathematically principled approaches to non-informative prior specification, but they can produce different results in different parameterizations.

Prior sensitivity analysis tests whether the conclusions change substantially under different reasonable prior specifications. If the posterior is robust across a range of priors, the results are credible regardless of prior choice. If the conclusions flip when the prior changes, the data are not informative enough to overcome prior uncertainty, and more data are needed.

Bayesian Design Optimization

Bayesian optimal design selects experimental conditions (sample sizes, treatment levels, measurement schedules) that maximize the expected information gain from the experiment. Unlike frequentist power analysis, which focuses solely on detecting a non-zero effect, Bayesian design optimization can target precision of parameter estimates, discrimination between competing models, or reduction in decision uncertainty.

Sequential Bayesian designs analyze data as they accumulate and use the current posterior to decide whether to continue collecting data, stop for futility, or stop because sufficient evidence has been obtained. Unlike frequentist sequential analysis, which requires pre-specified stopping rules and adjusted significance thresholds, Bayesian sequential analysis allows continuous monitoring of the evidence without inflating error rates. This flexibility can substantially reduce the average sample size needed to reach a conclusion.

When to Choose Bayesian Design

Bayesian experimental design is particularly valuable when prior information exists and ignoring it would be wasteful. In clinical research, for instance, Phase I and Phase II trials often generate substantial data about a treatment before the Phase III confirmatory trial begins. A Bayesian Phase III design can incorporate these earlier findings as informative priors, potentially requiring fewer participants to reach a conclusion than a frequentist design that starts from scratch.

Sequential and adaptive designs benefit especially from the Bayesian framework. Because Bayesian inference does not require corrections for multiple testing the way frequentist sequential analyses do, researchers can examine accumulating data at any point without inflating the false positive rate. This flexibility is valuable in settings where data arrive slowly, recruitment is difficult, or early stopping for efficacy or futility could prevent unnecessary participant exposure to inferior treatments.

Bayesian designs also excel in small-sample contexts where frequentist methods lose power and produce unreliable estimates. In rare disease research, educational interventions with limited classrooms, or ecological studies with few study sites, the ability to incorporate prior knowledge through informative priors can mean the difference between a study that produces actionable conclusions and one that is simply inconclusive. Even with small samples, Bayesian credible intervals provide direct probability statements about the parameter of interest, which many researchers and decision-makers find more intuitive than confidence intervals.

However, Bayesian methods are not universally superior. When strong prior information is unavailable and the goal is a straightforward comparison between two groups, frequentist methods are simpler to implement and easier to communicate to non-statistical audiences. The choice between frameworks should be driven by the research context, the availability of prior data, and the needs of the intended audience, not by ideological preference for one statistical philosophy over another.